The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway
Abstract
Reperfusion is a pre-requisite to salvaging viable myocardium, following an acute myocardial infarction. Reperfusion of ischaemic myocardium, however, is not without risk, as the act of reperfusion itself can paradoxically result in myocyte death: a phenomenon termed lethal reperfusion-induced injury. Therapeutic strategies that target and attenuate reperfusion-induced cell death may provide novel pharmacological agents, which can be used as an adjunct to current reperfusion therapy, to limit myocardial infarction. Recent evidence has implicated apoptotic cell death during the phase of reperfusion as an important contributor to lethal reperfusion-induced injury. Targeting anti-apoptotic mechanisms of cellular protection at the time of reperfusion may therefore offer a potential approach to attenuating reperfusion-induced cell death. In this regard, ischaemia-reperfusion has been shown to activate the anti-apoptotic pro-survival kinase signalling cascades, phosphatidylinositol-3-OH kinase (PI3K)-Akt and p42/p44 extra-cellular signal-regulated kinases (Erk 1/2), both of which have been implicated in cellular survival. Activating these pro-survival kinase cascades at the time of reperfusion has been demonstrated to confer protection against reperfusion-induced injury. We and others have shown that insulin, insulin-like growth factor-1 (IGF-1), transforming growth factor-beta1 (TGF-beta1), cardiotrophin-1 (CT-1), urocortin, atorvastatin and bradykinin protect the heart, by activating the PI3K-Akt and/or Erk 1/2 kinase cascades, when given at the commencement of reperfusion, following a lethal ischaemic insult. Pharmacological manipulation and up-regulation of these pro-survival kinase cascades, which we refer to as the Reperfusion Injury Salvage Kinase (RISK) pathway, as an adjunct to reperfusion may therefore protect the myocardium from lethal reperfusion-induced cell death and provide a novel strategy to salvaging viable myocardium and limiting infarct size.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
OLSSON, A. G., McMurray, J. J. V., Thorgeirsson, G., Spaulding, C. M., Slattery, J., Pyörälà, K., Færgeman, O., Wright, R. S., Berg, K. M., Wilhelmsen, L., et al. (1994) · The Lancet · Cited by 8,467
Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium.
Murry, C. E., Jennings, R. B., & Reimer, K. A. (1986) · Circulation · doi:10.1161/01.cir.74.5.1124 · Cited by 7,812
Murray, C. J., & Lopez, A. D. (1997) · The Lancet · doi:10.1016/s0140-6736(96)07492-2 · Cited by 7,007
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591 · cited 1×
“Phosphorylation and activation of endothelial nitric oxide synthase (eNOS) Akt has been shown to phosphorylate eNOS, producing nitric oxide which has been implicated in cellular protection [47].”
BackgroundPEDERSEN, T. R. (2004) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2004.08.027 · Cited by 3,106
Mitogen-Activated Protein Kinase: Conservation of a Three-Kinase Module From Yeast to Human
WIDMANN, C., GIBSON, S., JARPE, M. B., & JOHNSON, G. L. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.1.143 · Cited by 2,729
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,595
Schwartz, G. G. (2001) · JAMA · doi:10.1001/jama.285.13.1711 · Cited by 2,499
Regulation of Cell Death Protease Caspase-9 by Phosphorylation
Cardone, M. H., Roy, N., Stennicke, H. R., Salvesen, G. S., Franke, T. F., Stanbridge, E., Frisch, S., & Reed, J. C. (1998) · Science · doi:10.1126/science.282.5392.1318 · Cited by 2,481
THE MITOCHONDRIAL DEATH/LIFE REGULATOR IN APOPTOSIS AND NECROSIS
Kroemer, G., Dallaporta, B., & Resche-Rigon, M. (1998) · Annual Review of Physiology · doi:10.1146/annurev.physiol.60.1.619 · Cited by 1,963
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,901
Leist, M., Single, B., Castoldi, A. F., Kühnle, S., & Nicotera, P. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1481 · Cited by 1,871
Tuomilehto, J., Vidgren, G., Toivanen, L., Tuomilehto-Wolf, E., Kohtamaki, K., Stengård, J., Zimmet, P., Mackay, I. R., Rowley, M., & Koskela, P. (1994) · The Lancet · doi:10.1016/s0140-6736(94)92521-6 · Cited by 1,692
NF-κB is a target of AKT in anti-apoptotic PDGF signalling
Romashkova, J. A., & Makarov, S. S. (1999) · Nature · doi:10.1038/43474 · Cited by 1,517
gp 130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
Taga, T., & Kishimoto, T. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.797 · Cited by 1,461
Reperfusion injury induces apoptosis in rabbit cardiomyocytes.
Gottlieb, R. A., Burleson, K. O., Kloner, R. A., Babior, B. M., & Engler, R. L. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117504 · Cited by 1,441
Kureishi, Y., Luo, Z., Shiojima, I., Bialik, A., Fulton, D., Lefer, D. J., Sessa, W. C., & Walsh, K. (2000) · Nature Medicine · doi:10.1038/79510 · Cited by 1,439
Myocardial reperfusion: a double-edged sword?
Braunwald, E., & Kloner, R. A. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112160 · Cited by 1,367
Pleiotropic Effects of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors
Takemoto, M., & Liao, J. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1101.098486 · Cited by 1,272
Mayo, L. D., & Donner, D. B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.181181198 · Cited by 1,230
Bax and Adenine Nucleotide Translocator Cooperate in the Mitochondrial Control of Apoptosis
Marzo, I., Brenner, C., Zamzami, N., Jürgensmeier, J. M., Susin, S. A., Vieira, H. L. A., Prévost, M.-C., Xie, Z., Matsuyama, S., Reed, J. C., et al. (1998) · Science · doi:10.1126/science.281.5385.2027 · Cited by 1,168 · cited 1×
“In response to an apoptotic stimulus, the pro-apoptotic protein, Bax, undergoes a conformational change that allows it to translocate to the mitochondria [37,38], where it induces mitochondrial cytochrome c release by either forming a pore in the outer mitochondrial membrane itself or by interacting with and opening t…”
BackgroundProtein Kinase C Isotypes Controlled by Phosphoinositide 3-Kinase Through the Protein Kinase PDK1
Le Good, J. A., Ziegler, W. H., Parekh, D. B., Alessi, D. R., Cohen, P., & Parker, P. J. (1998) · Science · doi:10.1126/science.281.5385.2042 · Cited by 1,110
Preconditioning the myocardium: from cellular physiology to clinical cardiology
YELLON, D. M., & DOWNEY, J. M. (2003) · Physiological Reviews · doi:10.1152/physrev.00009.2003 · Cited by 1,062
Self-citationKajstura, J., Cheng, W. N., Krzysztof Reiss, F., CLARK, W. A., Sonnenblick, E. H., Krajewski, S., Reed, J., Olivetti, G., & Anversa, P. (1996) · PubMed · Cited by 1,039
More than one way to die: apoptosis, necrosis and reactive oxygen damage
Fiers, W., Beyaert, R., Declercq, W., & Vandenabeele, P. (1999) · Oncogene · doi:10.1038/sj.onc.1203249 · Cited by 864
The Ca2+-induced membrane transition in mitochondria
Hunter, D. R., & Haworth, R. A. (1979) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(79)90371-0 · Cited by 856
Fujio, Y., Nguyen, T., Wencker, D., Kitsis, R. N., & Walsh, K. (2000) · Circulation · doi:10.1161/01.cir.101.6.660 · Cited by 847
Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion
Griffiths, E. J., & Halestrap, A. P. (1995) · Biochemical Journal · doi:10.1042/bj3070093 · Cited by 838
Apoptosis in Ischemic and Reperfused Rat Myocardium
Fliss, H., & Gattinger, D. (1996) · Circulation Research · doi:10.1161/01.res.79.5.949 · Cited by 797
Bcl-2 Targets the Protein Kinase Raf-1 to Mitochondria
Wang, H.-G., Rapp, U. R., & Reed, J. C. (1996) · Cell · doi:10.1016/s0092-8674(00)81383-5 · Cited by 766
Serine/Threonine Protein Kinases and Apoptosis
Cross, T. G., Scheel-Toellner, D., Henriquez, N. V., Deacon, E., Salmon, M., & Lord, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4836 · Cited by 690
Párrizas, M., Saltiel, A. R., & LeRoith, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.1.154 · Cited by 653
Akt/Protein Kinase B Inhibits Cell Death by Preventing the Release of Cytochrome c from Mitochondria
Kennedy, S. G., Kandel, E. S., Cross, T. K., & Hay, N. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5800 · Cited by 651
Attenuation of Ischemia/Reperfusion Injury in Rats by a Caspase Inhibitor
Yaoita, H., Ogawa, K., Maehara, K., & Maruyama, Y. (1998) · Circulation · doi:10.1161/01.cir.97.3.276 · Cited by 626
Hausenloy, D. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00455-8 · Cited by 586
Self-citationProtection by Cyclosporin A of Ischemia/Reperfusion-Induced Damage in Isolated Rat Hearts
Griffiths, E. J., & Halestrap, A. P. (1993) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1993.1162 · Cited by 585
Expression cloning of cardiotrophin 1, a cytokine that induces cardiac myocyte hypertrophy.
Pennica, D., King, K. L., Shaw, K. J., Luis, E., Rullamas, J., Luoh, S. M., Darbonne, W. C., Knutzon, D. S., Yen, R., & Chien, K. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.4.1142 · Cited by 554
p70S6 kinase signals cell survival as well as growth, inactivating the pro-apoptotic molecule BAD
Harada, H., Andersen, J. S., Mann, M., Terada, N., & Korsmeyer, S. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171301998 · Cited by 549
Jonassen, A. K., Sack, M. N., Mjøs, O. D., & Yellon, D. M. (2001) · Circulation Research · doi:10.1161/hh2401.101385 · Cited by 523
Fibroblast Growth Factors as Multifunctional Signaling Factors
Szebenyi, G., & Fallon, J. F. (1998) · International Review of Cytology · doi:10.1016/s0074-7696(08)60149-7 · Cited by 484
Gao, F., Gao, E., Yue, T.-L., Ohlstein, E. H., Lopez, B. L., Christopher, T. A., & Ma, X.-L. (2002) · Circulation · doi:10.1161/01.cir.0000012529.00367.0f · Cited by 469
Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGF
Nakamura, T., Mizuno, S., Matsumoto, K., Sawa, Y., Matsuda, H., & Nakamura, T. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10226 · Cited by 434
Yue, T.-L., Wang, C., Gu, J.-L., Ma, X.-L., Kumar, S., Lee, J. C., Feuerstein, G. Z., Thomas, H., Maleeff, B., & Ohlstein, E. H. (2000) · Circulation Research · doi:10.1161/01.res.86.6.692 · Cited by 421
Yamaguchi, H., & Wang, H.-G. (2001) · Oncogene · doi:10.1038/sj.onc.1204984 · Cited by 412
Does reperfusion injury exist in humans?
Kloner, R. A. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90700-b · Cited by 401
Buerke, M., Murohara, T., Skurk, C., Nuss, C., Tomaselli, K., & Lefer, A. M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.17.8031 · Cited by 395
Sheng, Z., Knowlton, K., Chen, J., Hoshijima, M., Brown, J. H., & Chien, K. R. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5783 · Cited by 394
The Phosphatidylinositol 3-Kinase (PI3K)-Akt Pathway Suppresses Bax Translocation to Mitochondria
Tsuruta, F., Masuyama, N., & Gotoh, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108975200 · Cited by 383
Matsui, T., Li, L., del Monte, F., Fukui, Y., Franke, T. F., Hajjar, R. J., & Rosenzweig, A. (1999) · Circulation · doi:10.1161/01.cir.100.23.2373 · Cited by 383
Clarke, S. J., McStay, G. P., & Halestrap, A. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202191200 · Cited by 376
Ischemic Preconditioning Activates Phosphatidylinositol-3-Kinase Upstream of Protein Kinase C
Tong, H., Chen, W., Steenbergen, C., & Murphy, E. (2000) · Circulation Research · doi:10.1161/01.res.87.4.309 · Cited by 365
Reperfusion induces myocardial apoptotic cell death
Zhao, Z. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00354-5 · Cited by 308
Ohno, M., Takemura, G., Ohno, A., Misao, J., Hayakawa, Y., Minatoguchi, S., Fujiwara, T., & Fujiwara, H. (1998) · Circulation · doi:10.1161/01.cir.98.14.1422 · Cited by 308
Erhardt, P., Schremser, E. J., & Cooper, G. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5308 · Cited by 306
Caspase Inhibition Reduces Myocyte Cell Death Induced by Myocardial Ischemia and Reperfusion In Vivo
Holly, T. A., Drincic, A., Byun, Y., Nakamura, S., Harris, K., Klocke, F. J., & Cryns, V. L. (1999) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1006 · Cited by 303
Mediation of Cardioprotection by Transforming Growth Factor-β
Lefer, A. M., Tsao, P., Aoki, N., & Palladino, M. A. (1990) · Science · doi:10.1126/science.2164258 · Cited by 299
Apoptosis is Initiated by Myocardial Ischemia and Executed During Reperfusion
Freude, B., Masters, T. N., Robicsek, F., Fokin, A., Kostin, S., Zimmermann, R., Ullmann, C., Lorenz-Meyer, S., & Schaper, J. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.1999.1066 · Cited by 289
Regulation of Cardiomyocyte Apoptotic Signaling by Insulin-like Growth Factor I
Wang, L., Ma, W., Markovich, R., Chen, J.-W., & Wang, P. H. (1998) · Circulation Research · doi:10.1161/01.res.83.5.516 · Cited by 287
Akt Is a Direct Target of the Phosphatidylinositol 3-Kinase
Datta, K., Bellacosa, A., Chan, T. O., & Tsichlis, P. N. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.48.30835 · Cited by 279
Bell, R. M., & Yellon, D. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02816-4 · Cited by 261
p90RSK Blocks Bad-mediated Cell Death via a Protein Kinase C-dependent Pathway
Tan, Y., Ruan, H., Demeter, M. R., & Comb, M. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.34859 · Cited by 241
Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway
Brar, B. K., Jonassen, A. K., Stephanou, A., Santilli, G., Railson, J., Knight, R. A., Yellon, D. M., & Latchman, D. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.8508 · Cited by 236
Mocanu, M. M., Baxter, G. F., & Yellon, D. M. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703336 · Cited by 224
Progression of Myocardial Necrosis During Reperfusion of Ischemic Myocardium
Matsumura, K., Jeremy, R. W., Schaper, J., & Becker, L. C. (1998) · Circulation · doi:10.1161/01.cir.97.8.795 · Cited by 218
Apoptosis in Myocardial Ischemia‐Reperfusion
GOTTLIEB, R. A., & ENGLER, R. L. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09255.x · Cited by 213
Progressively developed myocardial apoptotic cell death during late phase of reperfusion
Zhao, Z.-Q., Velez, D. A., Wang, N.-P., Hewan-Lowe, K. O., Nakamura, M., Guyton, R. A., & Vinten-Johansen, J. (2001) · Apoptosis · doi:10.1023/a:1011335525219 · Cited by 207
Reperfusion injury on cardiac myocytes after simulated ischemia
Vanden Hoek, T. L., Shao, Z., Li, C., Zak, R., Schumacker, P. T., & Becker, L. B. (1996) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.1996.270.4.h1334 · Cited by 191
Bernier, S. G., Haldar, S., & Michel, T. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005116200 · Cited by 190
Schulte, G., & Fredholm, B. B. (2000) · PubMed · Cited by 188
Bell, R. (2003) · Journal of Molecular and Cellular Cardiology · doi:10.1016/s0022-2828(02)00310-3 · Cited by 182
Mocanu, M. M., Bell, R. M., & Yellon, D. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2006 · Cited by 178
Weston, C. R., Balmanno, K., Chalmers, C., Hadfield, K., Molton, S. A., Ley, R., Wagner, E. F., & Cook, S. J. (2003) · Oncogene · doi:10.1038/sj.onc.1206261 · Cited by 176
Jonassen, A. K., Brar, B. K., Mjøs, O. D., Sack, M. N., Latchman, D. S., & Yellon, D. M. (2000) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2000.1118 · Cited by 170
Fryer, R. M., Pratt, P. F., Hsu, A. K., & Gross, G. J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38785-3 · Cited by 165
Shimizu, N., Yoshiyama, M., Omura, T., Hanatani, A., Kim, S., Takeuchi, K., Iwao, H., & Yoshikawa, J. (1998) · Cardiovascular Research · doi:10.1016/s0008-6363(97)00327-1 · Cited by 161
Zhao, Z., Morris, C. D., Budde, J. M., Wang, N.-P., Muraki, S., Sun, H.-Y., & Guyton, R. A. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00344-4 · Cited by 157
Yamashita, K., Kajstura, J., Discher, D. J., Wasserlauf, B. J., Bishopric, N. H., Anversa, P., & Webster, K. A. (2001) · Circulation Research · doi:10.1161/01.res.88.6.609 · Cited by 152
Schwartz, G. G., OLSSON, A. G., & al, M. D. E. (2001) · ACC Current Journal Review · doi:10.1016/s1062-1458(01)00368-3 · Cited by 151
Yellon, D., & Baxter, G. F. (1999) · Trends in cardiovascular medicine · doi:10.1016/s1050-1738(00)00029-3 · Cited by 141
Liu, Y.-H., Yang, X.-P., Sharov, V. G., Sigmon, D. H., Sabbah, H. N., & Carretero, O. A. (1996) · Hypertension · doi:10.1161/01.hyp.27.1.7 · Cited by 141
Strickler, J. H., Jacobson, K. A., & Liang, B. T. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118976 · Cited by 134
Modulation of the Mitochondrial Permeability Transition by Nitric Oxide
Balakirev, M. Y., Khramtsov, V. V., & Zimmer, G. (1997) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1997.00710.x · Cited by 127
Activation of mitochondrial Raf-1 is involved in the antiapoptotic effects of Akt.
Majewski, M., Nieborowska-Skorska, M., Salomoni, P., Słupianek, A., Reiss, K., Trotta, R., Calabretta, B., & Skórski, T. (1999) · PubMed · Cited by 126
Baines, C. P., Wang, L., Cohen, M. V., & Downey, J. M. (1999) · Basic Research in Cardiology · doi:10.1007/s003950050142 · Cited by 126
Brar, B. K., Stephanou, A., Knight, R. A., & Latchman, D. S. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.1529 · Cited by 119
Glucose-Insulin-Potassium Reduces Infarct Size When Administered During Reperfusion
Jonassen, A. K., Aasum, E., Riemersma, R. A., Mjøs, O. D., & Larsen, T. S. (2000) · Cardiovascular Drugs and Therapy · doi:10.1023/a:1007802630604 · Cited by 118
Zingarelli, B., Hake, P. W., Yang, Z., O’Connor, M. P., Denenberg, A. G., & Wong, H. R. (2002) · The FASEB Journal · doi:10.1096/fj.01-0533com · Cited by 118
Bai, H.-Z., Pollman, M. J., Inishi, Y., & Gibbons, G. H. (1999) · Circulation Research · doi:10.1161/01.res.85.3.229 · Cited by 112
Brar, B. K., Stephanou, A., Liao, Z., O'Leary, R. M., Pennica, D., Yellon, D. M., & Latchman, D. S. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00294-2 · Cited by 111
CRH-like peptides protect cardiac myocytes from lethal ischaemic injury
Brar, B. K., Stephanou, A., Okosi, A., Lawrence, K. M., Knight, R. A., Marber, M. S., & Latchman, D. S. (1999) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(99)00183-5 · Cited by 109
Insulin therapy as an adjunct toreperfusion after acute coronary ischemia
Sack, M. N., & Yellon, D. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00164-5 · Cited by 105
Zhao, Z., Nakamura, M., Wang, N.-P., Velez, D. A., Hewan-Lowe, K. O., Guyton, R. A., & Vinten-Johansen, J. (2000) · Journal of Surgical Research · doi:10.1006/jsre.2000.6029 · Cited by 105
Liao, Z., Brar, B. K., Cai, Q., Stephanou, A., O'Leary, R. M., Pennica, D., Yellon, D. M., & Latchman, D. S. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00531-4 · Cited by 105
Vascular Endothelial Growth Factor Attenuates Myocardial Ischemia-Reperfusion Injury
Luo, Z., Diaco, M., Murohara, T., Ferrara, N., Isner, J. M., & Symes, J. F. (1997) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(97)00715-7 · Cited by 104
Adenosine A3receptor activation protects the myocardium from reperfusion/reoxygenation injury
Maddock, H. L., Mocanu, M. M., & Yellon, D. M. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00851.2001 · Cited by 103
Role of bradykinin in preconditioning and protection of the ischaemic myocardium
Baxter, G. F., & Ebrahim, Z. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704548 · Cited by 102
A coronary primary prevention study of Scottish men aged 45?64 years: Trial design
(1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90068-x · Cited by 98
The role of bradykinin and nitric oxide in the cardioprotective action of ACE inhibitors
Hartman, J. C. (1995) · The Annals of Thoracic Surgery · doi:10.1016/0003-4975(95)00192-n · Cited by 83
Apoptosis in myocardial infarction
Rodríguez, M., Lucchesi, B. R., & Schaper, J. (2002) · Annals of Medicine · doi:10.1080/078538902321012414 · Cited by 81
Zingarelli, B., Hake, P. W., Denenberg, A. G., & Wong, H. R. (2002) · Shock · doi:10.1097/00024382-200202000-00008 · Cited by 72
Pillai, S. B., Hinman, C. E., Luquette, M. H., Nowicki, P. T., & Besner, G. E. (1999) · Journal of Surgical Research · doi:10.1006/jsre.1999.5764 · Cited by 58
Scarabelli, T. M., Knight, R. A., Rayment, N. B., Cooper, T., Stephanou, A., Brar, B. K., Lawrence, K. M., Santilli, G., Latchman, D. S., Baxter, G. F., et al. (1999) · Journal of Immunological Methods · doi:10.1016/s0022-1759(99)00090-3 · Cited by 58
Angiogenesis-independent cardioprotection in FGF-1 transgenic mice
Buehler, A. (2002) · Cardiovascular Research · doi:10.1016/s0008-6363(02)00494-7 · Cited by 57
Fibroblast growth factor-1 prevents myocardial apoptosis triggered by ischemia reperfusion injury.
Cuevas, P., Reimers, D., Carceller, F., Martínez-Coso, V., Redondo‐Horcajo, M., de Tejada, I. S., & Giménez‐Gallego, G. (1997) · PubMed · Cited by 50
Li, Y., & Sato, T. (2001) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2001.1455 · Cited by 48
Taimor, G. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00209-0 · Cited by 48
[Regulatory mechanisms in focal cerebral ischemia. New possibilities in neuroprotective therapy].
Nagy, Z., Simon, L., & Bori, Z. (2002) · PubMed · Cited by 12
Cited by
Yellon, D. M., & Hausenloy, D. J. (2007) · New England Journal of Medicine · doi:10.1056/nejmra071667 · Cited by 3,797
Self-citationMechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Murphy, E., & Steenbergen, C. (2008) · Physiological Reviews · doi:10.1152/physrev.00024.2007 · Cited by 1,465
Arslan, F., Lai, R. C., Smeets, M. B., Akeroyd, L., Choo, A., Aguor, E. N. E., Timmers, L., van Rijen, H. V., Doevendans, P. A., Pasterkamp, G., et al. (2013) · Stem Cell Research · doi:10.1016/j.scr.2013.01.002 · Cited by 1,107
ROS and redox signaling in myocardial ischemia-reperfusion injury and cardioprotection
Cadenas, S. (2018) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.01.024 · Cited by 820
Heusch, G. (2015) · Circulation Research · doi:10.1161/circresaha.116.305348 · Cited by 811
Metadata
- Authors
- Hausenloy, D.
- Venue
- Cardiovascular Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2004-02-15
- Volume
- 61
- Issue
- 3
- Pages
- 448-460
- ISSN
- 0008-6363 (ISSN-L)
- OpenAlex
- W2147791296
- Cited by
- 996
- References
- 109
- FWCI
- 25.15
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.